Plexus Corp. (NASDAQ:PLXS) CFO Sells $485,899.77 in Stock

Plexus Corp. (NASDAQ:PLXS) CFO Patrick John Jermain sold 3,361 shares of the business’s stock in a transaction on Monday, January 27th. The stock was sold at an average price of $144.57, for a total value of $485,899.77. Following the sale, the chief financial officer now owns 20,745 shares of the company’s stock, valued at approximately $2,999,104.65. The trade was a 13.94 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Patrick John Jermain also recently made the following trade(s):

• On Wednesday, November 6th, Patrick John Jermain sold 2,643 shares of Plexus stock. The stock was sold at an average price of $166.32, for a total value of $439,583.76.

Plexus Price Performance

NASDAQ PLXS opened at $143.33 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.71 and a current ratio of 1.51. Plexus Corp. has a 52-week low of $90.18 and a 52-week high of $172.89. The business has a 50 day simple moving average of $161.17 and a 200 day simple moving average of $142.71. The stock has a market cap of $3.88 billion, a price-to-earnings ratio of 33.26 and a beta of 0.91.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings data on Wednesday, January 22nd. The technology company reported $1.49 EPS for the quarter, missing analysts’ consensus estimates of $1.59 by ($0.10). Plexus had a return on equity of 10.43% and a net margin of 3.03%. Analysts anticipate that Plexus Corp. will post 6.13 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. GSA Capital Partners LLP bought a new stake in Plexus in the 3rd quarter valued at approximately $899,000. Victory Capital Management Inc. lifted its position in shares of Plexus by 3.9% in the third quarter. Victory Capital Management Inc. now owns 200,186 shares of the technology company’s stock worth $27,367,000 after purchasing an additional 7,483 shares in the last quarter. Schaper Benz & Wise Investment Counsel Inc. WI boosted its holdings in Plexus by 62.6% during the third quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 13,346 shares of the technology company’s stock worth $1,825,000 after purchasing an additional 5,138 shares during the last quarter. Stifel Financial Corp bought a new position in Plexus in the third quarter valued at $332,000. Finally, Barclays PLC increased its stake in Plexus by 139.4% in the 3rd quarter. Barclays PLC now owns 48,786 shares of the technology company’s stock valued at $6,669,000 after buying an additional 28,406 shares during the last quarter. 94.45% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

PLXS has been the subject of several analyst reports. Stifel Nicolaus lifted their price target on shares of Plexus from $136.00 to $150.00 and gave the stock a “hold” rating in a research report on Tuesday, December 10th. Needham & Company LLC increased their price target on shares of Plexus from $162.00 to $172.00 and gave the company a “buy” rating in a research report on Friday, January 24th. StockNews.com upgraded shares of Plexus from a “hold” rating to a “buy” rating in a report on Monday, November 18th. Benchmark reiterated a “buy” rating and issued a $165.00 target price on shares of Plexus in a report on Wednesday, January 22nd. Finally, KeyCorp initiated coverage on shares of Plexus in a report on Tuesday, October 22nd. They issued a “sector weight” rating for the company. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $162.33.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.